From: Fractal analysis: a new biomarker for determining clot characteristics in critically ill patients
Mean Df
Mean MCF (mm)
Pre enoxaparin
1.79 ± 0.08
68.0 ± 8.0
Post enoxaparin
1.64 ± 0.10
64.3 ± 4.2